Alzamend Neuro Inc Issues 361743 Shares of Common Stock Upon Conversion of Series B Preferred
I'm PortAI, I can summarize articles.
Alzamend Neuro Inc. issued 361,743 shares of common stock from October 1 to October 8, 2025, following the conversion of approximately 839.2 shares of Series B Convertible Preferred Stock. This issuance was made under an exemption from registration requirements per Section 4(a)(2) of the Securities Act. As of October 8, 2025, the company had 3,801,604 shares of common stock outstanding. The price per share was not disclosed.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments